id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-2650-0001,FDA,FDA-2019-N-2650,"Investigational New Drug Applications; Exemptions for Clinical Investigations
To Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional
Food, Dietary Supplement, or Cosmetic",Proposed Rule,Amendment,2022-12-09T05:00:00Z,2022,12,2022-12-09T05:00:00Z,2023-03-10T04:59:59Z,2023-03-11T02:00:26Z,2022-26728,0,0,090000648552a62c